Drug-Induced Adverse Reactions
Drug-Induced Adverse Reactions is a research topic within Pharmacology. Science Explorer counts 24k research works in it since 1950. 13.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on hypersensitivity reactions to various drugs and medications, including the role of specific HLA genotypes such as HLA-B*5701, HLA-B*1502, and HLA-B*5801 in predicting severe cutaneous adverse reactions like Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. The cluster also covers topics related to drug-induced hypersensitivity syndrome (DIHS), delayed drug hypersensitivity reactions, and the use of genetic screening to prevent abacavir hypersensitivity reactions.
- HLA-B*5701
- Stevens-Johnson Syndrome
- Toxic Epidermal Necrolysis
- Drug Hypersensitivity
- Abacavir
- Carbamazepine
- Allopurinol
- DRESS Syndrome
- Immediate Allergic Reactions
- HLA Genotyping
- Research works
- 24k fractional, since 1950
- In the world top 10%
- 3.1k per year above
- Top-10% rate
- 13.0% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +34% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Drug-Induced Adverse Reactions research?
By volume, the United States and China publish the most (1k and 335 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1k works
- 2 China 335 works
- 3 India 333 works
- 4 Japan 224 works
- 5 France 194 works
- 6 Spain 182 works
- 7 United Kingdom 157 works
- 8 Türkiye 142 works
- 9 Germany 137 works
- 10 Italy 128 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Drug-Induced Adverse Reactions research?
By volume in 2022–2025, Vanderbilt University Medical Center publishes the most Drug-Induced Adverse Reactions research, followed by Sağlık Bilimleri Üniversitesi and Harvard University.
By volume, 2022–2025
- 1 Vanderbilt University Medical CenterUnited States 19 works
- 2 Sağlık Bilimleri ÜniversitesiTürkiye 16 works
- 3 Harvard UniversityUnited States 16 works
- 4 Massachusetts General HospitalUnited States 14 works
- 5 InsermFrance 14 works
- 6 Brigham and Women's HospitalUnited States 14 works
- 7 All India Institute of Medical SciencesIndia 13 works
- 8 Yale UniversityUnited States 13 works
- 9 Charité - Universitätsmedizin BerlinGermany 11 works
- 10 The University of Texas Southwestern Medical CenterUnited States 10 works
Who are the leading researchers in Drug-Induced Adverse Reactions?
The most-cited researchers publishing on Drug-Induced Adverse Reactions include Aziz Sheikh, Luigi Naldi and Trevor W. Robbins.
- 1 Aziz Sheikh United Kingdom 5.8k citations
- 2 Luigi Naldi Italy 4.7k citations
- 3 Trevor W. Robbins United Kingdom 3.1k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Drug-Induced Adverse Reactions research done?
The largest centres of Drug-Induced Adverse Reactions research in 2022–2025 are Paris (France), Tokyo (Japan), Madrid (Spain) and Beijing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Nashville.
Largest cities, 2022–2025
Where it is the local speciality
- NashvilleUS · 28.1 works7.3×
Location quotient: how much more of its research is in Drug-Induced Adverse Reactions than the world average.
Where is the best place to study Drug-Induced Adverse Reactions?
Among universities, judged by research, Harvard University, Sağlık Bilimleri Üniversitesi and Yale University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Harvard UniversityUnited States | 62.8 | 24.1% | 3.2× | 16 | +44.3% |
| 2 | Sağlık Bilimleri ÜniversitesiTürkiye | 49.6 | 4.3% | 7.1× | 16 | — |
| 3 | Yale UniversityUnited States | 40.3 | 13.1% | 3.2× | 13 | +36.5% |
| 4 | University of TorontoCanada | 40.1 | 25.2% | 1.5× | 8 | -9.5% |
| 5 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 35.8 | 26.1% | 2.1× | 8 | -17.9% |
| 6 | Philipps University of MarburgGermany | 35.4 | 4.8% | 9.4× | 9 | -40.6% |
| 7 | All India Institute of Medical SciencesIndia | 34.0 | 2.9% | 5.4× | 13 | +71.4% |
| 8 | Post Graduate Institute of Medical Education and ResearchIndia | 25.8 | 0.8% | 6.6× | 9 | +69.3% |
| 9 | Istanbul UniversityTürkiye | 23.6 | 4.3% | 5.5× | 8 | +3.0% |
| 10 | University of North Carolina at Chapel HillUnited States | 17.9 | 6.6% | 1.3× | 9 | +61.4% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Drug-Induced Adverse Reactions research growing?
Output in 2018–2022 was 34% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Drug-Induced Adverse Reactions.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.